Ledger.Open graph →
SEC Form D · filed October 9, 2018

OncBioMune Pharmaceuticals, Inc

Offering
$1.2M
Sold
$1.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BATON ROUGE, LA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Jonathan F. Head · Baton Rouge, LAExec · DirectorRobert N. Holcomb · Baton Rouge, LADirectorAndrew F. Kucharchuk · Baton Rouge, LAExecJonathan F. Head · Baton Rouge, LAExec · DirectorCharles L. Rice, Jr · Baton Rouge, LADirectorDaniel S. Hoverman · Baton Rouge, LADirectorTobias Hekster · Chicago, ILExec · DirectorRobert N. Holcomb · Baton Rouge, LADirectorCharles L. Rice, Jr · Baton Rouge, LADirectorAndrew F. Kucharchuk · Baton Rouge, LAExecDaniel S. Hoverman · Baton Rouge, LADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗